Before testing
Inheritance, recurrence risk, test scope and alternatives are explained.
Genetic counselling brings together family history, genetic test results and reproductive goals so that risks, options and uncertainties can be explained clearly.

The aim is not to direct you towards a particular option, but to consider risk, alternatives, test limitations and personal values together in an impartial way.
Inheritance, recurrence risk, test scope and alternatives are explained.
Reports, family pedigree and required samples are organised.
Results such as unaffected, carrier, affected, mosaic or uncertain are interpreted.
Prenatal screening and diagnostic options are considered according to individual preferences.
A structured healthcare service that connects genetic information with personal and family decision-making.
Genetic counselling translates family history and test results into understandable language, explains risk numerically and verbally, compares testing options and supports people in making decisions consistent with their own values.
In reproductive genetics, counselling is not simply about ordering a test. Which test answers the clinical question, what the test cannot show and which decisions the result may influence are discussed in advance.
For case-specific tests such as PGT-M, the clinical meaning of the family variant, inheritance pattern, required relative samples and laboratory feasibility are assessed. For PGT-A, routine use, mosaicism and the possibility of reducing the number of embryos available are discussed in a balanced way.
Counselling should be non-directive. Options such as natural conception, prenatal diagnosis, PGT, gamete donation, embryo donation, adoption or choosing not to pursue pregnancy can be considered in the context of personal values and medical circumstances.

Testing generates data; counselling explains what the data mean, their limits and how they may affect decisions.
Considers risk, options, uncertainty, family implications and personal values together.
Investigates a defined genetic finding in blood, saliva or embryo samples.
No. It may also be useful for carrier status, recurrent miscarriage, a family history of genetic disease, a karyotype finding, advanced parental age, a previous affected pregnancy or an uncertain test result.
Assessment may be appropriate whenever a genetic risk or test result could influence reproductive decision-making.
A known or suspected inherited condition in the family.
Couples carrying variants for the same recessive condition or an X-linked risk.
A translocation, inversion or another chromosome rearrangement.
A genetic finding in a parent or pregnancy tissue.
Those wishing to understand the potential benefits and limitations of PGT-A, PGT-M or PGT-SR.
Situations requiring interpretation of a VUS, mosaic or unexpected genetic finding.
No. Counselling supports people in understanding information and options so that they can make their own decision. Choosing not to test is also a valid part of the process.
Complete documentation helps improve risk assessment and can reduce unnecessary repeat testing.
Full copies of karyotype, panel, exome, carrier-screening or previous PGT results.
Diagnoses and pregnancy losses in parents, siblings, children and close relatives.
Records of miscarriage, stillbirth, prenatal diagnosis and congenital differences.
Oocyte, blastocyst, biopsy and transfer outcomes.
Relevant specialist reports, pathology or imaging findings.
Priorities relating to test purpose, cost, timing, privacy and result management.
The consultation is a broader decision-making process than simply gathering information and sharing a result.
The family’s main question and reproductive goal are identified.
At least a three-generation pedigree and relevant health history are prepared.
The variant, karyotype or test result is verified.
The inheritance pattern and individual recurrence risk are explained.
Natural conception, prenatal testing, PGT and other reproductive options are considered.
The selected test’s scope, limitations and possible results are documented.
The clinical meaning of the report and implications for family members are explained.
Embryo transfer, pregnancy testing, prenatal diagnosis or family testing is planned when appropriate.
One consultation may be sufficient, while PGT-M cases or uncertain results may require more than one appointment.
A structured assessment according to the complexity of the file.
Collection of missing genetic reports or family samples.
Technical feasibility assessment for PGT-M or PGT-SR.
Completion of the selected genetic test.
Reassessment of the report and available options.
Additional consultation when considering prenatal screening or diagnosis.
Genetic counselling can often be provided online. There is no need to remain physically in Cyprus for counselling alone; if IVF or another procedure is planned, a treatment-specific visit schedule is prepared.
The aim is not to produce one “correct decision”, but to create an informed decision-making process that is appropriate for the individual.
Incomplete or incorrect variant information can change the risk assessment.
A detailed pedigree can help clarify the inheritance pattern and need for additional testing.
Experience in reproductive genetics and PGT is important for complex results.
Options should be presented clearly without directing the patient towards a particular choice.
VUS findings, reduced penetrance and mosaicism should be discussed realistically.
Accurate information transfer between genetics, IVF, embryology and pregnancy-care teams is essential.
The success of genetic counselling is not measured by how often people choose testing, but by whether they understand risks, alternatives and uncertainties well enough to make a decision consistent with their own values.
Cost may vary according to file complexity, number of consultations and any additional laboratory review.
Assessment of family history, reports and genetic risk.
Multiple affected family members or a complex inheritance pattern.
Specialist interpretation of karyotype, panel, exome or PGT reports.
PGT-M test development or PGT-SR feasibility review.
Explanation of a new report and development of a decision plan.
Planning embryo transfer or prenatal testing during pregnancy.
Send your genetic reports in advance so the scope of the consultation and need for any additional review can be clarified beforehand.
Genetic information is sensitive health data that can affect not only the individual but also family members.
The laboratory name, sample, method, variant and classification are checked.
The family member to whom the report belongs and the relationship are recorded accurately.
Variant classifications and report revisions are documented.
Genetic data are accessible only to authorised team members and are shared according to consent.
The PGT report is verified against the correct embryo and patient record.
The pregnancy-care team receives accurate information about the test scope and residual risks.

Integrating genetic risk into reproductive treatment requires collaboration between clinical, embryology and appropriately qualified genetics professionals.

Assesses how genetic risk may affect ovarian stimulation, embryo planning and transfer timing.
View profile →
Coordinates genetic counselling, scientific quality, consent and multidisciplinary communication.
View profile →
When PGT is planned, manages biopsy, freezing, reporting and the embryo-identity chain.
View profile →Clinical interpretation of genetic risk and test results should involve an appropriately qualified medical geneticist or genetic counsellor. The IVF and embryology team manages integration of testing into reproductive treatment.
Genetic information does not always provide a definite prediction and may change as scientific knowledge develops.
A VUS or reduced penetrance does not provide a definite prediction of disease.
Relatives without a diagnosis or available reports can limit risk assessment.
A negative result does not exclude all genetic conditions.
Variants may be reclassified as new evidence becomes available.
Results may create guilt, anxiety or difficulties in family communication.
Testing, data sharing and reproductive options can vary according to the regulations of the relevant country.
Answers about who may benefit, what happens during a consultation and how results are managed.
A structured healthcare service that assesses family history and genetic test results and explains risks, options and uncertainties.
It may be recommended for people with a family history of genetic disease, carrier status, a karyotype finding, recurrent miscarriage or a plan for PGT.
Available information is reviewed first; appropriate testing options may then be recommended when needed.
No. All options, including proceeding with or without PGT, are considered impartially.
It helps clarify inheritance patterns, affected relatives and the need for additional testing.
A classification used when current evidence is insufficient to determine whether a genetic change is associated with disease.
No. Genetic changes outside the test scope or newly arising changes may still occur.
Variant classifications may be updated as new scientific evidence emerges.
Yes, particularly for carrier, mosaic, no-result or complex reports.
PGT does not exclude all fetal genetic conditions and there is a small possibility of an incorrect result.
Genetic reports, diagnoses in family members, karyotypes, pregnancy history and previous IVF results.
Yes, for many cases; original reports can be shared securely in advance.
No stay is required for counselling alone; if IVF or another procedure is planned, a separate schedule is prepared.
File complexity, number of consultations, report review and laboratory coordination.